BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 17166107)

  • 21. Gestational diabetes, pregnancy hypertension, and late vascular disease.
    Carpenter MW
    Diabetes Care; 2007 Jul; 30 Suppl 2():S246-50. PubMed ID: 17596480
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of TCF7L2 polymorphism with diabetes mellitus, metabolic syndrome, and markers of beta cell function and insulin resistance in a population-based sample of Emirati subjects.
    Saadi H; Nagelkerke N; Carruthers SG; Benedict S; Abdulkhalek S; Reed R; Lukic M; Nicholls MG
    Diabetes Res Clin Pract; 2008 Jun; 80(3):392-8. PubMed ID: 18282631
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
    Resmini E; Minuto F; Colao A; Ferone D
    Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Obesity, metabolic syndrome and sleep apnoea: all pro-inflammatory states.
    Alam I; Lewis K; Stephens JW; Baxter JN
    Obes Rev; 2007 Mar; 8(2):119-27. PubMed ID: 17300278
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of patients with acanthosis nigricans skin lesion for hyperinsulinemia, insulin resistance and diabetes risk.
    Gilkison C; Stuart CA
    Nurse Pract; 1992 Feb; 17(2):26, 28, 37 passim. PubMed ID: 1542462
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The metabolic syndrome: metabolic changes with vascular consequences.
    Wassink AM; Olijhoek JK; Visseren FL
    Eur J Clin Invest; 2007 Jan; 37(1):8-17. PubMed ID: 17181562
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiovascular metabolic syndrome - an interplay of, obesity, inflammation, diabetes and coronary heart disease.
    Rana JS; Nieuwdorp M; Jukema JW; Kastelein JJ
    Diabetes Obes Metab; 2007 May; 9(3):218-32. PubMed ID: 17391148
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Levels of C3 in patients with severe, morbid and extreme obesity: its relationship to insulin resistance and different cardiovascular risk factors.
    Hernández-Mijares A; Jarabo-Bueno MM; López-Ruiz A; Solá-Izquierdo E; Morillas-Ariño C; Martínez-Triguero ML
    Int J Obes (Lond); 2007 Jun; 31(6):927-32. PubMed ID: 17264851
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Poor vitamin D status may contribute to high risk for insulin resistance, obesity, and cardiovascular disease in Asian Indians.
    McCarty MF
    Med Hypotheses; 2009 Jun; 72(6):647-51. PubMed ID: 19217213
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The metabolic syndrome in hypertension: European society of hypertension position statement.
    Redon J; Cifkova R; Laurent S; Nilsson P; Narkiewicz K; Erdine S; Mancia G;
    J Hypertens; 2008 Oct; 26(10):1891-900. PubMed ID: 18806611
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Screening for type 2 diabetes in children with acanthosis nigricans.
    Hardin DS
    Diabetes Educ; 2006; 32(4):547-52. PubMed ID: 16873592
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Evaluation and prevention of type II diabetes mellitus and cardiovascular diseases in obese children and adolescents: a public health intervention in a local health organisation in Rome (Italy)].
    Doro Altan AM; Manca Bitti ML; Buonomo E; Scarcella P; Mancinelli S; Arcano S; Palombi L
    Ig Sanita Pubbl; 2008; 64(3):345-60. PubMed ID: 18936798
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Polycystic ovary syndrome in the Indian Subcontinent.
    Allahbadia GN; Merchant R
    Semin Reprod Med; 2008 Jan; 26(1):22-34. PubMed ID: 18181079
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Type 2 diabetes mellitus: a high-risk condition for cardiovascular disease irrespective of the different degrees of obesity.
    Song SH; Hardisty CA
    QJM; 2008 Nov; 101(11):875-9. PubMed ID: 18776208
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Insulin resistance: related clinical syndromes].
    Cangemi C; Lombardo G; Sinagra D
    Recenti Prog Med; 1993; 84(7-8):541-50. PubMed ID: 8356310
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prediabetes and type 2 diabetes in youth: an emerging epidemic disease?
    Cali AM; Caprio S
    Curr Opin Endocrinol Diabetes Obes; 2008 Apr; 15(2):123-7. PubMed ID: 18316946
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of insulin resistance, dyslipidemia, and intra-abdominal adiposity on the development of cardiovascular disease and diabetes mellitus.
    Rader DJ
    Am J Med; 2007 Mar; 120(3 Suppl 1):S12-8. PubMed ID: 17320517
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Obesity; epiphenomenon or cause of metabolic syndrome?
    Lois K; Young J; Kumar S
    Int J Clin Pract; 2008 Jun; 62(6):932-8. PubMed ID: 18479286
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A diabetes risk score helps identify metabolic syndrome and cardiovascular risk in Indians - the Chennai Urban Rural Epidemiology Study (CURES-38).
    Mohan V; Sandeep S; Deepa M; Gokulakrishnan K; Datta M; Deepa R
    Diabetes Obes Metab; 2007 May; 9(3):337-43. PubMed ID: 17391160
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Insulin resistance markers in children.
    Eyzaguirre F; Mericq V
    Horm Res; 2009; 71(2):65-74. PubMed ID: 19129710
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.